Provided by Tiger Trade Technology Pte. Ltd.

Cytokinetics

65.65
-0.2600-0.39%
Volume:1.16M
Turnover:76.93M
Market Cap:9.13B
PE:-9.14
High:67.27
Open:65.73
Low:65.30
Close:65.91
52wk High:88.31
52wk Low:53.61
Shares:139.02M
Float Shares:138.02M
Volume Ratio:0.52
T/O Rate:0.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.1827
EPS(LYR):-6.5400
ROE:-572.15%
ROA:-28.09%
PB:-52.61
PE(LYR):-10.04

Loading ...

Cytokinetics CEO Robert I. Blum Disposes of 7,500 Common Shares for $615,150

Reuters
·
Jul 15

How Myqorzo’s US and German Launches Will Impact Cytokinetics (CYTK) Investors

Simply Wall St.
·
Jul 12

Larimar, Cytokinetics, Itau, Global-e, Immunovant Shake-Up

TIPRANKS
·
Jul 11

High-Profile Insider Trade Shakes Up Cytokinetics Watchlist

TIPRANKS
·
Jul 08

Cytokinetics EVP R&D Malik Fady Ibraham Disposes of 3,500 Common Shares Worth $303,170

Reuters
·
Jul 08

Cytokinetics is Maintained at Outperform by RBC Capital

Dow Jones
·
Jul 08

RBC Capital Adjusts Cytokinetics Price Target to $117 From $119, Maintains Outperform Rating

MT Newswires Live
·
Jul 07

Cytokinetics Releases ESC 2026 Late-breaking Abstracts Update

Reuters
·
Jul 07

Cytokinetics Announces Three Late-breaking Science Abstracts at the European Society of Cardiology (esc) Congress 2026

THOMSON REUTERS
·
Jul 07

Cytokinetics Announces Three Late-Breaking Science Abstracts at the European Society of Cardiology (ESC) Congress 2026

GlobeNewswire
·
Jul 07

CYTK, PRME, DOCS, WBD, LQDA Trending With Analysts

TIPRANKS
·
Jul 04

Top Cytokinetics Insiders Quietly Cash In With Major Stock Sales

TIPRANKS
·
Jul 03

Cytokinetics CFO Sung Lee Disposes of 1,112 Common Shares for $97,618.48

Reuters
·
Jul 03

Cytokinetics CFO Lee Sung Reports Sale of 3,134 Common Shares Valued at $266,390

Reuters
·
Jun 30

Cytokinetics Seen Gaining From Myqorzo Momentum to Treat Heart Conditions, UBS Says

MT Newswires Live
·
Jun 30

Cytokinetics Raised to Buy from Neutral by UBS

Dow Jones
·
Jun 30

Cytokinetics Inc : UBS Raises to Buy from Neutral

THOMSON REUTERS
·
Jun 29

UBS Upgrades Cytokinetics to Buy From Neutral, Adjusts Price Target to $115 From $69

MT Newswires Live
·
Jun 29

Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY) and Cytokinetics (CYTK)

TIPRANKS
·
Jun 29

S&P 500 Futures Drop in Premarket Trading; on Semiconductor, Davita Lag

Dow Jones
·
Jun 26